LONDON and OXFORD, England, Aug.

OXFORD, England, July 18, 2011 /PRNewswire/ -- In October 2007, Enigma Diagnostics (Porton Down, UK & San Diego, USA) announced the award of a euro 3 Million grant by the European Commission Framework 7 programme.

MILTON PARK, OXFORD, England and SAN DIEGO, April 11, 2011 /PRNewswire/ -- Enigma Diagnostics announced today that it has commenced clinical trials for its intended point of care Enigma® ML Influenza A/B detection assay. Enigma will submit its application to the U.S.

OXFORD, England, Oct.

OXFORD, England and SAN DIEGO, July 21 /PRNewswire/ -- Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced today that it is featuring the Enigma ML (Mini-Laboratory) at this year's American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo, July 25-29 at the Anaheim Convention Center in Anaheim, California.